April 26, 2023: INO-3107 / HPV-related diseases / Inovio Pharmaceuticals: Positive COMP opinion for Orphan Drug Designation in EU
INOVIO announced that the European Committee for Orphan Medicinal Products provided a positive opinion on the company’s application for orphan drug designation in the European Union for INO-3107
European Commission to review and make a final decision, expected late May 2023